AURO-AMOXICILLIN CAPSULE

国家: 加拿大

语言: 英文

来源: Health Canada

现在购买

下载 产品特点 (SPC)
02-11-2023

有效成分:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE)

可用日期:

AURO PHARMA INC

ATC代码:

J01CA04

INN(国际名称):

AMOXICILLIN

剂量:

500MG

药物剂型:

CAPSULE

组成:

AMOXICILLIN (AMOXICILLIN TRIHYDRATE) 500MG

给药途径:

ORAL

每包单位数:

30/100/500

处方类型:

Prescription

治疗领域:

AMINOPENICILLINS

產品總結:

Active ingredient group (AIG) number: 0131314006; AHFS:

授权状态:

APPROVED

授权日期:

2012-06-27

产品特点

                                Auro-Amoxicillin Product Monograph
Page 1 of 28
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
Pr
Auro-Amoxicillin
Amoxicillin Capsules
Capsules, 250 mg and 500 mg amoxicillin (as amoxicillin trihydrate),
Oral
BP
Antibiotic
AURO PHARMA INC.
3700 Steeles Avenue West, Suite #
402 Woodbridge, Ontario, L4L 8K8
Canada
Date of Initial Authorization:
JUN 27, 2012
Date of Revision:
NOV 02, 2023
Submission Control Number: 276668
Auro-Amoxicillin Product Monograph
Page 2 of 28
RECENT MAJOR LABEL CHANGES
3 SERIOUS WARNINGS AND PRECAUTIONS BOX
10/2023
7 WARNINGS AND PRECAUTIONS
10/2023
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.....................................................................
4
1 INDICATIONS
......................................................................................................................
4
1.1 Pediatrics
...............................................................................................................................
4
1.2 Geriatrics
...............................................................................................................................
4
2. CONTRAINDICATIONS
........................................................................................................
4
3 SERIOUS WARNINGS AND PRECAUTIONS BOX
.....................................................................
5
4 DOSAGE AND ADMINISTRATION
.........................................................................................
5
4.1 Dosing Considerations
...........................................................................................................
5
4.2 Recommended Dose and Dosage Adjustment Usual Dosage
............................................... 5
4.4 Administration
.......................................................................................................................
7
4.5 Missed Dose
..........................................................................................................................
7
5 OVERDOSAGE
....
                                
                                阅读完整的文件
                                
                            

其他语言的文件

产品特点 产品特点 法文 02-11-2023

搜索与此产品相关的警报